|
SUPT16H expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04459999999518E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.30510000000562E-05 |
| Normal-vs-Stage2 |
1.457590E-03 |
| Normal-vs-Stage3 |
1.023610E-04 |
| Normal-vs-Stage4 |
7.92170000000203E-05 |
| Stage1-vs-Stage2 |
8.580400E-01 |
| Stage1-vs-Stage3 |
9.002600E-01 |
| Stage1-vs-Stage4 |
7.689000E-01 |
| Stage2-vs-Stage3 |
9.331000E-01 |
| Stage2-vs-Stage4 |
9.764600E-01 |
| Stage3-vs-Stage4 |
8.833400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.31029999999688E-05 |
| Normal-vs-AfricanAmerican |
3.155800E-01 |
| Normal-vs-Asian |
9.115400E-03 |
| Caucasian-vs-AfricanAmerican |
6.778000E-02 |
| Caucasian-vs-Asian |
3.300400E-01 |
| AfricanAmerican-vs-Asian |
3.229200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.03309999999846E-05 |
| Normal-vs-Female |
6.22710000000026E-05 |
| Male-vs-Female |
4.000600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.406700E-04 |
| Normal-vs-Age(41-60Yrs) |
9.88279999999397E-05 |
| Normal-vs-Age(61-80Yrs) |
3.97340000000135E-05 |
| Normal-vs-Age(81-100Yrs) |
1.704250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.242400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.303800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.216200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.402200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.478400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.220400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.184600E-01 |
| Classical-VS-Follicular |
2.93230000003586E-06 |
| Classical-VS-Other |
2.399800E-01 |
| Classical-VS-Normal |
2.420100E-03 |
| Tall-VS-Follicular |
3.284100E-02 |
| Tall-VS-Other |
6.179600E-01 |
| Tall-VS-Normal |
2.621600E-03 |
| Follicular-VS-Other |
5.907600E-01 |
| Follicular-VS-Normal |
6.34440000535363E-08 |
| Other-VS-Normal |
3.407700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1499000000258E-06 |
| Normal-vs-N1 |
1.80911999999589E-05 |
| N0-vs-N1 |
6.088000E-01 |
|
|
